Your independent, local healthcare industry supplier, for more than 45 years

2024 Flu Season

Flu Season is Coming!

The World Health Organisation has released its recommendations for the viral composition of influenza vaccines for the upcoming 2024 influenza season.
To coincide, early bird orders for 2024 influenza vaccines are now available.

Not sure how to submit your early bird order? Here's how:

  1. Go to sssaustralia.com.au and log in to your account
  2. Navigate to sssaustralia.com.au/flu, or click the banner in your dashboard
  3. Add to cart the 2024 vaccines you would like to pre-order
  4. Complete your basket (feel free to do this as a part of another order)
  5. In the check out, in the order comments, let us know which month/s you would like your vaccines delivered, for example, if you ordered 10 boxes of 10, you may say “March: 2 boxes, April: 2 boxes, May: 6 boxes”
  6. Place order (you won’t be charged until your vaccines are despatched)
If you need any assistance, please call our customer support team on 
1800 777 518. Alternatively, if you would like to order via email, complete the form on the other side of this flyer and email to sales@sssaustralia.com.au
SCHEDULED MEDICINE
P.O.A. inc GST (B10)
Quantity In Cart:  
SCHEDULED MEDICINE
P.O.A. inc GST (B5)
Quantity In Cart:  
SCHEDULED MEDICINE
P.O.A. inc GST (B10)
Quantity In Cart:  
SCHEDULED MEDICINE
P.O.A. inc GST (B5)
Quantity In Cart:  

Learn about advancements in Influenza Vaccine Technology through this free Health Ed for Nurses short course online now!

Infectious Disease Physician and Clinical Microbiologist, A/Prof Paul Griffin, explains Australia’s advances in influenza vaccine technology, as well as the differences between influenza vaccines and why this is important to understand in order to better inform patients of the choices available.

Click here to access now!

The WHO recommends that trivalent vaccines for use in the 2024 southern hemisphere influenza season contain the following: 

Egg-based vaccines

  • an A/Victoria/4897/2022 (H1N1)pdm09-like virus;
  • an A/Thailand/8/2022 (H3N2)-like virus; and
  • a B/Austria/1359417/2021 (B/Victoria lineage)-like virus.

Cell culture- or recombinant-based vaccines

  • an A/Wisconsin/67/2022 (H1N1)pdm09-like virus;
  • an A/Massachusetts/18/2022 (H3N2)-like virus; and
  • a B/Austria/1359417/2021 (B/Victoria lineage)-like virus.

For quadrivalent egg- or cell culture-based or recombinant vaccines for use in 2024 southern hemisphere influenza season, the WHO recommends inclusion of the following B/Yamagata lineage component:

a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus.

Products to compare:
Comparing Products